Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quanterix Corp (NQ: QTRX )

12.78 +0.37 (+2.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 221,776
Open 12.50
Bid (Size) 12.26 (1)
Ask (Size) 13.30 (1)
Prev. Close 12.41
Today's Range 12.45 - 12.85
52wk Range 10.50 - 29.70
Shares Outstanding 38,063,618
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Quanterix Welcomes Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors
From Quanterix Corporation
Via Business Wire
Quanterix Announces Commercialization of p-Tau 217 Test Kit
From Quanterix Corporation
Via Business Wire

Performance

YTD
-52.93%
-52.93%
1 Month
-9.62%
-9.62%
3 Month
-11.25%
-11.25%
6 Month
-19.27%
-19.27%
1 Year
-35.78%
-35.78%

More News

Read More
Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
Quanterix Corp. (NASDAQ: QTRX) Highlighted for Surprising Price Action
Via Investor Brand Network
Earnings Scheduled For February 29, 2024
Via Benzinga
Jeffrey Elliott Appointed to Quanterix’s Board of Directors
From Quanterix Corporation
Via Business Wire
QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Quanterix Releases Financial Results for the Second Quarter of 2024
From Quanterix Corporation
Via Business Wire
Quanterix Presenting at Canaccord Genuity 44th Annual Growth Conference
From Quanterix Corporation
Via Business Wire
Earnings Preview: Quanterix
Via Benzinga
Earnings Scheduled For February 27, 2024
Via Benzinga
Quanterix To Report Second Quarter 2024 Financial Results
From Quanterix Corporation
Via Business Wire
Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimer’s Disease Detection that is More Effective than Standalone Plasma p-Tau 217
From Quanterix Corporation
Via Business Wire
Quanterix to Participate at the Scotiabank Healthcare 1x1 Day
From Quanterix Corporation
Via Business Wire
A Preview Of Quanterix's Earnings
Via Benzinga
Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024
From Quanterix Corporation
Via Business Wire
QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Quanterix Releases Financial Results for the First Quarter of 2024
From Quanterix Corporation
Via Business Wire
Quanterix To Report First Quarter 2024 Financial Results
From Quanterix Corporation
Via Business Wire
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
From Quanterix
Via Business Wire
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
From Quanterix Corporation
Via Business Wire
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023
From Quanterix Corporation
Via Business Wire
Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance
From Quanterix Corporation
Via Business Wire
Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease
From Quanterix Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.